Last CNY13.82 CNY
Change Today -0.34 / -2.40%
Volume 3.4M
002566 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 2:00 AM 12/17/14 All times are local (Market data is delayed by at least 15 minutes).

jilin jian yisheng pharmac-a (002566) Snapshot

Open
CNY14.12
Previous Close
CNY14.16
Day High
CNY14.12
Day Low
CNY13.70
52 Week High
12/19/13 - CNY17.60
52 Week Low
03/28/14 - CNY12.51
Market Cap
4.6B
Average Volume 10 Days
4.5M
EPS TTM
CNY0.27
Shares Outstanding
331.0M
EX-Date
05/22/14
P/E TM
51.8x
Dividend
CNY0.07
Dividend Yield
0.48%
Current Stock Chart for JILIN JIAN YISHENG PHARMAC-A (002566)

Related News

No related news articles were found.

jilin jian yisheng pharmac-a (002566) Related Businessweek News

No Related Businessweek News Found

jilin jian yisheng pharmac-a (002566) Details

Jilin Jian Yisheng Pharmaceutical Co., Ltd. engages in the research, development, production, and distribution of Chinese patent drugs for the treatment of cardiovascular and cerebrovascular diseases. Its principal products include Shengmai injections, Zhenyuan capsules, Xinyue capsules, Qingkailing injections, and Guifu Dihuang capsules. The company offers drug class products covering medicine to protect species, non-prescription drugs, essential drugs, and others; participation products, such as Moods and Zhenyuan capsules, as well as Ginseng resorcinol compound liniments; and Bee class products consisting of Honey, a nutritious food; Propolis, a natural immune enhancer; Royal jelly, a royal jelly ingredient; Pollen, a high-protein low-fat nutrition; and Gift Series products. Its products are also used for respiratory, alimentary, endocrine, and urinary system diseases; tumors and paediatric diseases; and others. The company is based in Ji'an, China.

jilin jian yisheng pharmac-a (002566) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jilin jian yisheng pharmac-a (002566) Key Developments

Jilin Jian Yisheng Pharmaceutical Co., Ltd. Amends its Articles of Association

Jilin Jian Yisheng Pharmaceutical Co., Ltd. announced that at the Extraordinary General Meeting of the company held on November 12, 2014, the company approved amendments to its articles of association.

Jilin Jian Yisheng Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Nov 12, 2014

Jilin Jian Yisheng Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Nov 12, 2014., at 14:00 China Standard Time. Agenda: To consider adjustment to the investment quota and implementation schedule for the projects financed by raised funds; to consider termination of implementation of a project; to consider amendments to the Company's articles of association; to consider amendments to the Company's rules of procedures governing shareholders' general meetings; to consider amendments to the management measures on financing and external guarantee; to consider by-election of independent directors; to consider adjustment to remuneration for independent directors; and to consider application for working capital loan.

Jilin Jian Yisheng Pharmaceutical Proposes Amendment to Articles of Association

Jilin Jian Yisheng Pharmaceutical Co., Ltd. announced that at the 2nd Extraordinary General Meeting of 2014 to be held on November 12, 2014, the company proposes to amend articles of association.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002566:CH CNY13.82 CNY -0.34

002566 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002566.
View Industry Companies
 

Industry Analysis

002566

Industry Average

Valuation 002566 Industry Range
Price/Earnings 56.0x
Price/Sales 6.2x
Price/Book 2.5x
Price/Cash Flow 54.6x
TEV/Sales 5.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JILIN JIAN YISHENG PHARMAC-A, please visit www.yisheng-pharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.